We are live on
!
Find out more
Acadia Pharmaceuticals
ACAD
ACAD
235 hedge funds and large institutions have $3.81B invested in Acadia Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 76 increasing their positions, 76 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
123% more call options, than puts
Call options by funds: $12.4M | Put options by funds: $5.54M
60% more funds holding in top 10
Funds holding in top 10: 5 → 8 (+3)
28% more capital invested
Capital invested by funds: $2.97B → $3.81B (+$838M)
17% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 29
1% more funds holding
Funds holding: 232 → 235 (+3)
0.88% more ownership
Funds ownership: 97% → 97.88% (+0.88%)
0% more repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 76
Holders
235
Holders Change
+3
Holders Change %
+1.29%
% of All Funds
3.69%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.13%
New
34
Increased
76
Reduced
76
Closed
29
Calls
$12.4M
Puts
$5.54M
Net Calls
+$6.81M
Net Calls Change
+$425K
Top Buyers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$51.7M |
| 2 |
RI
RTW Investments
New York
|
+$34.2M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$32.5M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$20.9M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$20.6M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$56.1M |
| 2 |
JP Morgan Chase
New York
|
-$29M |
| 3 |
Millennium Management
New York
|
-$28.1M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$22.2M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$13.2M |
